A detailed history of J. Goldman & CO LP transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, J. Goldman & CO LP holds 63,437 shares of GILD stock, worth $5.96 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
63,437
Previous 35,735 77.52%
Holding current value
$5.96 Million
Previous $2.45 Million 116.93%
% of portfolio
0.17%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$66.59 - $83.99 $1.84 Million - $2.33 Million
27,702 Added 77.52%
63,437 $5.32 Million
Q2 2024

Aug 14, 2024

BUY
$63.15 - $72.88 $2.26 Million - $2.6 Million
35,735 New
35,735 $2.45 Million
Q4 2023

Feb 14, 2024

BUY
$73.27 - $83.09 $1.75 Million - $1.98 Million
23,862 New
23,862 $1.93 Million
Q4 2022

Feb 14, 2023

BUY
$62.32 - $89.47 $11 Million - $15.8 Million
176,697 New
176,697 $15.2 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track J. Goldman & CO LP Portfolio

Follow J. Goldman & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.